Search
for
Sort by
Research 781–810 of 1000+
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- <i>N</i>1-acetylspermidine is a determinant of hair follicle stem cell fate
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Current best evidence in pigmentary dermatology
- Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study
- Efficacy of oral tofacitinib in moderate to severe alopecia areata, totalis and universalis at the tertiary care hospital, Karachi
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Update on pulse corticosteroid therapy for the management of alopecia areata
- New therapies for alopecia areata
- Multifocal alopecia of the scalp, axillae, and body
- Upadacitinib for the treatment of alopecia areata – A case report
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment